High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells

Stem Cells
Uri Ben-David, Nissim Benvenisty

Abstract

Mouse pluripotent stem cells (PSCs) are the best studied pluripotent system and are regarded as the "gold standard" to which human PSCs are compared. However, while the genomic integrity of human PSCs has recently drawn much attention, mouse PSCs have not been systematically evaluated in this regard. The genomic stability of PSCs is a matter of profound significance, as it affects their pluripotency, differentiation, and tumorigenicity. We thus performed a thorough analysis of the genomic integrity of 325 samples of mouse PSCs, including 127 induced pluripotent stem cell (iPSC) samples. We found that genomic aberrations occur frequently in mouse embryonic stem cells of various mouse strains, add in mouse iPSCs of various cell origins and derivation techniques. Four hotspots of chromosomal aberrations were detected: full trisomy 11 (with a minimally recurrent gain in 11qE2), full trisomy 8, and deletions in chromosomes 10qB and 14qC-14qE. The most recurrent aberration in mouse PSCs, gain 11qE2, turned out to be fully syntenic to the common aberration 17q25 in human PSCs, while other recurrent aberrations were found to be species specific. Analysis of chromosomal aberrations in 74 samples of rhesus macaque PSCs revealed a gain in...Continue Reading

References

Dec 15, 1995·European Journal of Biochemistry·N van BelzenF T Bosman
May 1, 1997·Developmental Dynamics : an Official Publication of the American Association of Anatomists·X LiuR Jaenisch
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Rachel B CervantesPeter J Stambrook
Jun 28, 2002·Cancer Cell·Asaf HellmanBatsheva Kerem
Nov 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ayumi MatsuyamaCarlo M Croce
Oct 21, 2005·Cancer Letters·Michal SchwartzBatsheva Kerem
Feb 9, 2007·Nature Biotechnology·Duncan E C BakerPeter W Andrews
Apr 14, 2007·Science·UNKNOWN Rhesus Macaque Genome Sequencing and Analysis ConsortiumAnn S Zwieg
Nov 26, 2008·Nature Biotechnology·Claudia SpitsKaren Sermon
Nov 26, 2008·Nature Biotechnology·Nathalie LefortAnselme L Perrier
Nov 6, 2009·Cell Cycle·Barak Blum, Nissim Benvenisty
Feb 19, 2010·Nature·Graham R BignellMichael R Stratton
May 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jacob HannaRudolf Jaenisch
Oct 21, 2010·Stem Cells·Zuzana HolubcováAleš Hampl
Nov 3, 2010·Cell Stem Cell·Christa Buecker, Niels Geijsen
Feb 12, 2011·Cell Death and Differentiation·C E PasiT D Halazonetis
Mar 4, 2011·Nature·Samer M HusseinTimo Otonkoski
Mar 11, 2011·Nature Reviews. Cancer·Uri Ben-David, Nissim Benvenisty
Apr 12, 2011·Nature Biotechnology·Seth M TaapkenKaren D Montgomery
Sep 9, 2011·Nature·Martin Leeb, Anton Wutz

❮ Previous
Next ❯

Citations

Dec 5, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·So Gun HongThomas Winkler
Sep 12, 2012·Nature Reviews. Genetics·Riikka J LundRiitta Lahesmaa
Dec 12, 2012·Human Reproduction Update·H T NguyenC Spits
Aug 5, 2015·Journal of Clinical Medicine·Youssef Hibaoui, Anis Feki
Jan 22, 2014·The Journal of Cell Biology·Uri WeissbeinUri Ben-David
Oct 9, 2012·Current Opinion in Genetics & Development·Daniel Ronen, Nissim Benvenisty
Mar 11, 2016·Cellular and Molecular Life Sciences : CMLS·Paola RebuzziniSilvia Garagna
Sep 22, 2012·Biochimica Et Biophysica Acta·Pratik NagariaFeyruz V Rassool
Dec 3, 2014·Stem Cell Research·Daniel J CooperJohn R McCarrey
May 25, 2016·Current Opinion in Genetics & Development·Riikka H Hämäläinen
Jul 8, 2016·Nature Communications·Uri WeissbeinNissim Benvenisty
Mar 14, 2014·Cell Transplantation·Karthyayani RajamaniTzyy-Wen Chiou
Apr 11, 2019·Cellular Reprogramming·Laura TarnawskiStefan Jovinge
Dec 24, 2013·The Journal of Biological Chemistry·John Harding, Oleg Mirochnitchenko
Sep 25, 2019·Nature Reviews. Genetics·Uri Ben-David, Angelika Amon
Feb 28, 2015·Stem Cells Translational Medicine·James A HeslopB Kevin Park
Mar 3, 2019·Journal of Clinical Medicine·Stephen W Attwood, Michael J Edel
Dec 3, 2016·Cell Biology and Toxicology·Dharmendra KumarWilfried A Kues
May 27, 2021·Stem Cells and Development·Marion J RiggsRaj R Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.